2027 Medicare Advantage & Part D Final Rule: National Impact for Beneficiaries
2027 Medicare Advantage & Part D Final Rule: What It Means for Medicare Beneficiaries Nationwide
Updated for Contract Year 2027 — A clear breakdown of CMS’s latest rule changes affecting Medicare Advantage and Part D plans across the United States.
Overview: Why the 2027 Final Rule Matters
The Centers for Medicare & Medicaid Services (CMS) has finalized the Contract Year 2027 Medicare Advantage and Part D Rule. These updates reshape how plans are rated, how prescription drug coverage works, and how supplemental benefits are administered.
Whether you’re enrolled in a Medicare Advantage plan or a standalone Part D drug plan, these changes will affect your coverage, costs, and plan choices starting in 2027.
1. Star Ratings Overhaul: Focus on Outcomes
- No new Health Equity Index reward: CMS will not implement the proposed equity-based bonus for 2027.
- Plans can still earn bonuses for consistent high performance.
- 11 measures removed: Mostly administrative or “topped out” metrics with little variation.
- New measure added: Depression Screening & Follow-Up (Part C), starting with 2027 data.
These changes aim to make Star Ratings more meaningful by emphasizing clinical outcomes and patient experience.
2. Part D Prescription Drug Changes: IRA Rules Codified
- Coverage gap eliminated: The “donut hole” phase is removed.
- $0 cost sharing in catastrophic phase: Beneficiaries will pay nothing once they reach the annual cap.
- Lower annual out-of-pocket maximum: A firm cap on drug spending is now permanent.
- New Manufacturer Discount Program: Replaces the old Coverage Gap Discount Program.
- Updated rules: TrOOP calculations, specialty tiers, reinsurance payments, and subsidy implementation are all revised.
These updates make drug costs more predictable and reduce financial risk for Medicare beneficiaries.
3. Supplemental Benefits: Clearer Rules & Restrictions
- No cannabis products allowed: Plans cannot offer cannabis-based benefits if illegal under federal or state law.
- SSBCI eligibility must be posted: Plans must clearly define who qualifies for Special Supplemental Benefits for the Chronically Ill.
- Debit card rules finalized: Cards must be electronically linked to covered items, verified in real time, and expire at year-end.
These rules improve transparency and consistency in how supplemental benefits are offered and used.
4. Reduced Administrative Burden
- Creditable coverage notices removed: No longer required for account-based plans like HRAs, FSAs, and HSAs.
- Mid-year benefit notices eliminated: Plans no longer need to notify members about unused supplemental benefits.
- Quality improvement program changes: Health disparity reduction activities are no longer mandatory.
- LINET call center hours reduced: No longer required to operate 8am–8pm nationwide.
- Agent/broker conversation rules relaxed: Fewer restrictions on when and how beneficiaries can speak with licensed agents.
These changes streamline operations for plans and agents, allowing more focus on service and education.
5. Future Focus: CMS Requests Feedback
CMS also issued Requests for Information (RFIs) on:
- Marketing oversight and agent/broker regulation
- Dual-eligible enrollment in Chronic Condition SNPs
- Nutrition and well-being supports in Medicare Advantage
- Streamlining Medicare regulations
These RFIs signal potential areas for future rulemaking and program evolution.
Conclusion: What Beneficiaries Should Know
- Star Ratings will better reflect real health outcomes
- Part D drug costs will be capped and simplified
- Supplemental benefits will be more structured and transparent
- Plans and agents face fewer administrative hurdles
Official Sources
- CMS Fact Sheet: Contract Year 2027 Medicare Advantage and Part D Final Rule (CMS.gov)
- Federal Register: Official Publication of the Final Rule
These changes aim to improve plan quality, reduce costs, and simplify Medicare for beneficiaries across the country.
Frequently Asked Questions: CY 2027 Medicare Final Rule
What are the major changes to Medicare Star Ratings in 2027?
The 2027 Final Rule streamlines the Star Ratings system by removing 11 administrative measures to focus on clinical outcomes. It also introduces a new Depression Screening and Follow-Up measure and defers the implementation of the Health Equity Index reward to maintain stability in current scoring structures.
How does the 2027 Final Rule impact Medicare Part D drug costs?
The rule codifies key provisions of the Inflation Reduction Act (IRA), which include:
- The complete elimination of the Part D “Donut Hole” (coverage gap).
- The transition to the new Manufacturer Discount Program.
- Reduced annual out-of-pocket thresholds for beneficiaries.
What is the status of the Health Equity Index (HEI) in the 2027 rule?
CMS decided not to move forward with the proposed “Excellent Health Outcomes for All” (HEI) reward for the 2027 Star Ratings cycle. Instead, the agency will continue using the historical reward factor while they refine how to best incentivize health equity performance.